Verily launched self-serve access to its Pre Platform, including three new massive datasets:
Acute Myeloid Leukemia (AML) pipeline with single-cell transcriptomics from RefinedScience, real-world breast imaging data from Segmed (558 DBT exams with 271 malignant lesions), and rare disease CRISPRi maps from Transcripta Bio.2
Users can access datasets after standard DUAs, analyze collections like Project Baseline Health Study, and use up to five collaborative Workbench workspaces with visualization and analytics tools for free.2
The Pre Platform harmonizes multimodal health data using a FHIR-based model, powers AI research, and supports solutions like Verily Me app and Lightpath care program.13
This update democratizes access to clinical research data via a SaaS model, enhancing security, governance, and compute where data lives.2
Sources:
1. https://verily.com/solutions/pre-platform
2. https://hitconsultant.net/2026/02/19/verily-pre-platform-self-serve-ai-data-exchange/